September 28, 20090BioSante (NASDAQ: BPAX): LibiGel Provides Big Upside Potential On 9/22/09, BioSante and Cell Genesys (NASDAQ: CEGE) announced that they have determined the final exchange ratio will be 0.1828 in connection with the previously announced merger between the companies.
